Abstract

In the Firmicutes phylum, GpsB is a membrane associated protein that coordinates peptidoglycan synthesis with cell growth and division. Although GpsB has been studied in several bacteria, the structure, function, and interactome of Staphylococcus aureus GpsB is largely uncharacterized. To address this knowledge gap, we solved the crystal structure of the N-terminal domain of S. aureus GpsB, which adopts an atypical, asymmetric dimer, and demonstrates major conformational flexibility that can be mapped to a hinge region formed by a three-residue insertion exclusive to Staphylococci. When this three-residue insertion is excised, its thermal stability increases, and the mutant no longer produces a previously reported lethal phenotype when overexpressed in Bacillus subtilis. In S. aureus, we show that these hinge mutants are less functional and speculate that the conformational flexibility imparted by the hinge region may serve as a dynamic switch to finetune the function of the GpsB complex and/or to promote interaction with its various partners. Furthermore, we provide the first biochemical, biophysical, and crystallographic evidence that the N-terminal domain of GpsB binds not only PBP4, but also FtsZ, through a conserved recognition motif located on their C-termini, thus coupling peptidoglycan synthesis to cell division. Taken together, the unique structure of S. aureus GpsB and its direct interaction with FtsZ/PBP4 provide deeper insight into the central role of GpsB in S. aureus cell division.

Data availability

All crystal structures have been deposited in the RCSB Protein Data Bank (PDB) with accession IDs of: Sa GpsB NTD (PDB ID 8E2B), Sa GpsB NTD + Sa PBP4 C-term (PDB ID 8E2C).

The following data sets were generated

Article and author information

Author details

  1. Michael D Sacco

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Lauren R Hammond

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Radwan E Noor

    Global and Planetary Health, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Dipanwita Bhattacharya

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Lily J McKnight

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jesper J Madsen

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1411-9080
  7. Xiujun Zhang

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Shane G Butler

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. M Trent Kemp

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Aiden C Jaskolka-Brown

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Sebastian J Khan

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Ioannis Gelis

    Department of Chemistry, University of South Florida, Tampa, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Prahathees Eswara

    Department of Molecular Biosciences, University of South Florida, Tampa, United States
    For correspondence
    eswara@usf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4430-261X
  14. Yu Chen

    Department of Molecular Medicine, University of South Florida, Tampa, United States
    For correspondence
    ychen1@usf.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5115-3600

Funding

National Institutes of Health (R21 AI164775)

  • Yu Chen

National Institutes of Health (R35 GM133617)

  • Prahathees Eswara

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2024, Sacco et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,193
    views
  • 167
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael D Sacco
  2. Lauren R Hammond
  3. Radwan E Noor
  4. Dipanwita Bhattacharya
  5. Lily J McKnight
  6. Jesper J Madsen
  7. Xiujun Zhang
  8. Shane G Butler
  9. M Trent Kemp
  10. Aiden C Jaskolka-Brown
  11. Sebastian J Khan
  12. Ioannis Gelis
  13. Prahathees Eswara
  14. Yu Chen
(2024)
Staphylococcus aureus FtsZ and PBP4 bind to the conformationally dynamic N-terminal domain of GpsB
eLife 13:e85579.
https://doi.org/10.7554/eLife.85579

Share this article

https://doi.org/10.7554/eLife.85579

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Mai Nguyen, Elda Bauda ... Cecile Morlot
    Research Article

    Teichoic acids (TA) are linear phospho-saccharidic polymers and important constituents of the cell envelope of Gram-positive bacteria, either bound to the peptidoglycan as wall teichoic acids (WTA) or to the membrane as lipoteichoic acids (LTA). The composition of TA varies greatly but the presence of both WTA and LTA is highly conserved, hinting at an underlying fundamental function that is distinct from their specific roles in diverse organisms. We report the observation of a periplasmic space in Streptococcus pneumoniae by cryo-electron microscopy of vitreous sections. The thickness and appearance of this region change upon deletion of genes involved in the attachment of TA, supporting their role in the maintenance of a periplasmic space in Gram-positive bacteria as a possible universal function. Consequences of these mutations were further examined by super-resolved microscopy, following metabolic labeling and fluorophore coupling by click chemistry. This novel labeling method also enabled in-gel analysis of cell fractions. With this approach, we were able to titrate the actual amount of TA per cell and to determine the ratio of WTA to LTA. In addition, we followed the change of TA length during growth phases, and discovered that a mutant devoid of LTA accumulates the membrane-bound polymerized TA precursor.

    1. Microbiology and Infectious Disease
    Ziyu Wen, Pingchao Li ... Caijun Sun
    Research Article

    The persistence of latent viral reservoirs remains the major obstacle to eradicating human immunodeficiency virus (HIV). We herein found that ICP34.5 can act as an antagonistic factor for the reactivation of HIV latency by herpes simplex virus type I (HSV-1), and thus recombinant HSV-1 with ICP34.5 deletion could more effectively reactivate HIV latency than its wild-type counterpart. Mechanistically, HSV-ΔICP34.5 promoted the phosphorylation of HSF1 by decreasing the recruitment of protein phosphatase 1 (PP1α), thus effectively binding to the HIV LTR to reactivate the latent reservoirs. In addition, HSV-ΔICP34.5 enhanced the phosphorylation of IKKα/β through the degradation of IκBα, leading to p65 accumulation in the nucleus to elicit NF-κB pathway-dependent reactivation of HIV latency. Then, we constructed the recombinant HSV-ΔICP34.5 expressing simian immunodeficiency virus (SIV) env, gag, or the fusion antigen sPD1-SIVgag as a therapeutic vaccine, aiming to achieve a functional cure by simultaneously reactivating viral latency and eliciting antigen-specific immune responses. Results showed that these constructs effectively elicited SIV-specific immune responses, reactivated SIV latency, and delayed viral rebound after the interruption of antiretroviral therapy (ART) in chronically SIV-infected rhesus macaques. Collectively, these findings provide insights into the rational design of HSV-vectored therapeutic strategies for pursuing an HIV functional cure.